This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Welcome to BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna

Weitao Jia
Director, CMC Analytical Development Technical Operations at Ultragenyx
Speaker

Profile

Dr. Weitao Jia is the Director in CMC Analytical Development at Ultragenyx, California. He is currently leading a late-stage BLA project and working on a few early-stage development projects including mRNA-based therapeutics. Dr. Jia was previously working at Roche/Genentech for 9 years and was the CMC characterization/analytical lead as well as the global analytical technology transfer lead of Susvimo® which received FDA’s approval in October 2021. He earned his Ph.D. in Analytical Chemistry and gained extensive CMC development experiences via working on a few BLA projects with successful commercial launches and leading characterization/analytical work for Phase I/III INDs/CTAs.

Agenda Sessions

  • Chair’s Welcome Remarks: Manufacturing Strategy & Bioprocessing 4.0

    10:55